Martek Biosciences Settles Securities Case For $6M

Law360, New York (February 7, 2008, 12:00 AM EST) -- A judge will consider in April whether to give final approval to a proposed $6 million settlement of a class action alleging that Martek Biosciences Corp. violated securities laws and misled investors.

The class, which the court certified in September 2006, includes anyone who bought or acquired common stock of Martek between Dec. 9, 2004 and April 28, 2005.

Judge Marvin J. Garbis of the U.S. District Court for the District of Maryland gave the agreement preliminary approval of the deal, which was first filed in...
To view the full article, register now.